Pura Vida Investments’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-352,569
Closed -$4.17M 23
2024
Q3
$4.21M Buy
352,569
+72,569
+26% +$627K 2.75% 17
2024
Q2
$1.61M Buy
+280,000
New +$1.54M 1.02% 31
2023
Q1
Sell
-25,000
Closed -$65.3K 97
2022
Q4
$65.3K Sell
25,000
-561,696
-96% -$2.45M ﹤0.01% 188
2022
Q3
$4.11M Sell
586,696
-12,384
-2% -$97K 0.24% 100
2022
Q2
$4.09M Buy
599,080
+43,170
+8% +$440K 0.24% 98
2022
Q1
$7.84M Buy
555,910
+3,700
+0.7% +$49.5K 0.25% 95
2021
Q4
$8M Buy
552,210
+123,081
+29% +$1.75M 0.29% 87
2021
Q3
$6.08M Sell
429,129
-115,416
-21% -$1.78M 0.18% 134
2021
Q2
$9.58M Sell
544,545
-332,517
-38% -$5.36M 0.3% 77
2021
Q1
$13.4M Buy
+877,062
New +$12.5M 0.38% 57

Other funds holding BVS

Pura Vida Investments's BVS Position: Q4 2024 in Review

Pura Vida Investments sold out of Bioventus (BVS) in Q4 2024, closing a stake of 352,569 shares — an estimated $4.17M sold.

Pura Vida Investments first reported a position in BVS in Q1 2021 and held it in 10 quarters. The position peaked at $13.4M in Q1 2021. 151 funds tracked by Wall St. Rank hold BVS as of Q4 2024.

  • Pura Vida Investments reported no remaining Bioventus position as of Q4 2024 after selling out during the quarter.
  • Pura Vida Investments sold 352,569 Bioventus shares in Q4 2024, an estimated $4.17M.
  • Pura Vida Investments first reported a position in Bioventus in Q1 2021 and held it in 10 quarters.
  • Pura Vida Investments's Bioventus position peaked at $13.4M in Q1 2021.
  • 151 funds tracked by Wall St. Rank held Bioventus as of Q4 2024.

Based on Pura Vida Investments's 13F filing for Q4 2024, filed 12 Feb 2025.